Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Unraveling the Microenvironment and the Pathogenic Axis of HIF‐1α–Visfatin–Fibrosis in Autoimmune Pancreatitis Using a Single‐Cell Atlas
Zhang, Deyu , Ma, Congjia , Liu, Yanfang , Liu, Zaoqu, Li, Wanshun , Liu, Yue , Wu, Chang , Sun, Liqi , Jiang, Fei , Jiang, Hui , Su, Xiaoju, Peng, Lisi , Wang, Xinyue , Yin, Hua, Wan, Dongling, Zhou, Yuyan , Tian, Xiaorong , Li, Shiyu , Jin, Zhendong , Ji, Baoan , Li, Zhaoshen , Huang, Haojie , Wang, Zhen , Huang, Haojie , Wang, Zhen , Li, Jiayu , Li, Zhaoshen

Mayo Clinic

Advanced Science | January 31, 2025 | Volume: 12 | Issue: 12 | Pages: No page available

10.1002/advs.202412282 | PMID 39887620 Get It

AbstractAutoimmune pancreatitis (AIP) is identified as a severe chronic immune‐related disorder in pancreas, including two subtypes. In this study, pancreatic lesions in patients diagnosed as either type 1 AIP or type 2 AIP are examined, and these patients’ peripheral blood at single‐cell level. Furthermore, flow cytometry, immunofluorescence, and functional assays are performed to verify the identified cell subtypes. In type 1 AIP, there is a notable increase in the amount of B cells and plasma cells, and IgG4+ plasma cells are key pathogenic cells of AIP. The differentiation path of naïve‐stage B cells into IgG4+ produced plasma cells is observed, and an increased amount of T helper cells and T follicular helper (Tfh) cells. This study also reveals that HIF‐1α, an activated transcriptional factor, can directly bind to promoter site of NAMPT, promoting higher levels of visfatin production in HIF1A+ classical monocytes. Pancreatic stellate cells can be activated by extracellular visfatin and promote the development of fibrotic response in pancreatic lesions across both AIP subtypes. The current findings shed light on the exploration of dynamic alterations in peripheral blood cells and cell subgroups in pancreatic lesions of AIP, while elucidating a pathogenic cell subset and potential fibrosis mechanism of AIP.
Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer
Ekstrom, Thomas L. , Abdelrahman, Amro M. , Parassiadis, Christina, Manjunath, Meghana, Dittrich, Marianna Y, Kutschat, Ana P. , Kanakan, Akshay , Schacherer, Nadine , Lukic, Teodora , Carlson, Danielle M. , Thiel, Julia , Kopp, Waltraut, Stroebel, Philipp, Ellenrieder, Volker , Gaedcke, Jochen , Truty, Mark J. , Heßmann, Elisabeth , Johnsen, Steven A. , Manjunath, Meghana , Kutschat, Ana Patricia , Ellenrieder, Volker , Johnsen, Steven A , Abdelrahman, Amro M , Rosok, Raya M. , Dittrich, Marianna Y, Wang, Xin , Rajput, Ashish, Carlson, Danielle Marie , Dong, Meng, Najafova, Zeynab

Mayo Clinic

Gut | January 30, 2025 | Volume: 74 | Issue: 7 | Pages: 1112-1124

10.1136/gutjnl-2024-334374 | PMID 39884837 Get It

Background Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a 5-year survival rate of 12%. It has two major molecular subtypes: classical and basal, regulated by the master transcription factors (MTFs) GATA6 and ΔNp63, respectively. Objective This study sought to uncover the transcriptional regulatory mechanisms controlling PDAC subtype identity. Design We integrated primary tumour single-cell RNA-seq, patient-derived xenograft RNA-seq and multispectral imaging to identify MTF-dependent, subtype-specific markers. We created subtype-specific fluorescent reporter systems and conducted drug screenings to find actionable targets. We analysed chromatin accessibility (ATAC-seq), genome-wide occupancy (ChIP-seq) for epigenetic status (H3K27ac), MTFs (GATA6, ΔNp63), RNA polymerase II (Pol II), H3K4me3-anchored chromatin topology (HiChIP) and nascent RNA capture sequencing (PRO-seq). Additionally, we used nuclease-dead Cas9 (dCas9) to manipulate transcriptional regulatory mechanisms. Results Our approach identified glucocorticoid receptor (GR) agonists as agents that suppress the classical transcriptional programme by interacting with GATA6. GATA6 regulates classical-specific transcription through promoter-proximal pause release. Depletion of GATA6 increased Pol II occupancy at GATA6-bound enhancers and transcriptional start sites, stabilising enhancer–promoter interactions. Artificially inducing pausing at GATA6-bound enhancers with dCas9 abrogated target gene expression and induced pausing at both the enhancer and target gene promoter. Conversely, in basal PDAC ΔNp63 promotes Pol II recruitment and stabilises enhancer–promoter interactions. Conclusion This study provides new insights into the transcriptional control and role of GR agonists in controlling PDAC molecular subtype identity.
Hypointense Findings on Hepatobiliary Phase MR Images
Harper, Kelly , Ronot, Maxime , Wells, Michael , Luna, Antonio , Ba‐Ssalamah, Ahmed , Wang, Jin , Welle, Christopher L. , Silva, Alvin C. , Fidler, Jeff L. , Venkatesh, Sudhakar K. , Harper, Kelly C, Wells, Michael L , Fidler, Jeff L. , Venkatesh, Sudhakar K

Mayo Clinic

RadioGraphics | January 30, 2025 | Volume: 45 | Issue: 2 | Pages: No page available

10.1148/rg.240090 | PMID 39883575 Get It

Encompassing a broad spectrum of abnormalities from diffuse liver disorders to focal liver lesions, hypointense findings on hepatobiliary phase MR images offer valuable diagnostic information, provide insight on the functional status of the liver, and aid in characterization of other imaging features.
Abstract WP58: Retinal Optical Coherence Tomography Abnormalities Associated with CADASIL: A Case-Control Study from the UK Biobank
Vallamchetla, Sai Krishna , Badr, Amro , Dumitrascu, Oana M. , Abdelkader, Omar, Shourav, Md Manjurul Islam , Li, Xin, Wang, Yalin , Meschia, James F. , Lin, Michelle J.

Mayo Clinic

Stroke | January 30, 2025 | Volume: 56 | Issue: Suppl_1 | Pages: No page available

10.1161/str.56.suppl_1.wp58 Get It

Introduction: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebral small vessel disease, yet there is currently no biomarker for early detection. This study aims to identify retinal biomarkers of NOTCH3 carriers using optical coherence tomography (OCT) from the UK Biobank. Methods: We conducted a cross-sectional, matched case-control study of individuals with or without CADASIL from the UK Biobank between 2006 and 2010. All participants had retinal OCT scan and cognitive assessment. Cases were identified based on pathogenic NOTCH3 mutations and 1:1 matched with healthy controls based on age, sex, hypertension, diabetes mellitus, and smoking status. Baseline characteristics and cognitive test scores were compared using chi-square or Mann-Whitney-U test appropriately. Macular thickness (central, inner, and outer subfields) (Figure) and retinal nerve fiber layer (RNFL) thickness were compared using Wilcoxon signed-rank test. Results: Our analysis included 134 participants (67 CADASIL cases, 67 controls) with a mean age of 54±8 years. There were no differences in visual acuity between the two groups. CADASIL performed worse in prospective memory (0.043), verbal and numerical reasoning (p=0.178), visual memory (p=0.227), and processing speed (p=0.101) than matched controls. Participants with CADASIL had significantly thinner macular inner subfield at the superior (p=0.006), temporal (p=0.008), and nasal (p=0.034) quadrants, and significantly thinner RNFL (p=0.008) compared to controls (Table). Conclusion: Individuals with CADASIL have reduced thickness in the inner macular subfield and RFNL relative to matched controls. These retinal group differences were not associated with differences in visual acuity and may reflect early pericyte dysfunction and microvascular ischemia. Longitudinal studies are needed to assess the temporal relationship between these retinal changes and disease progression.
Penile prosthesis for erectile dysfunction: recommendations from the 5th International Consultation on Sexual Medicine
Köhler, Tobias S. , Munarriz, Ricardo , Parker, Justin , Hatzichristodoulou, Georgios , Moncada, Ignacio , Park, Sung Hun, Ralph, David , Wang, Run , Bettocchi, Carlo , Martins, Francisco E. , Osmonov, Daniar

Mayo Clinic

Sexual Medicine Reviews | January 30, 2025 | Volume: 13 | Issue: 2 | Pages: 144-171

10.1093/sxmrev/qeaf001 | PMID 40072010 Get It

Abstract Introduction Penile prosthesis (PP) is one of the main approved therapies for erectile dysfunction (ED). Greater than 50 years of clinical use has led to considerable innovation in PP surgery and patient care. Objectives To summarize the current literature and provide updated clinical evidence to inform healthcare providers on best practices with PP. Methods A consensus panel was held with leading sexual medicine experts during the 5th International Consultation on Sexual Medicine (ICSM). Relevant peer-reviewed literature was reviewed with focus on research from but not limited to the last 10 years. The quality of each individual study was judged with Oxford levels of evidence (LOE) criteria, but overall LOE were not used as systematic review was not performed. The expert panel generated consensus statements based on the quality of evidence and criteria of GRADE (Grading of Recommendations Assessment, Development and Evaluation). Results PP provides excellent outcomes for the treatment of ED. The panel developed 35 recommendations building upon previous recommendations. Nine recommendations (4, 5, 11,13,17, 25, 26, 31, and 32) are retained without change from 2015. Twelve recommendations (1, 2, 3, 7, 9,14,16,19,21, 28, 33, and 34) change syntax to make statements more active or change details. Fourteen recommendations (6, 8, 10, 12, 15, 18, 20, 22, 23, 24, 27, 29, 30, and 35) are novel in this update. Conclusion Since the 4th ICSM, new evidence has emerged to guide PP use in modern sexual medicine. While multi-institutional studies are needed to improve outcomes, key challenges remain: reducing infections, enhancing devices, and improving awareness and accessibility. We recommend following 5th ICSM guidelines while emphasizing the importance of clinical judgment and shared decision-making for optimal PP outcomes.
Left ventricular force with resting volumetric transthoracic echocardiography identifies different phenotypes in heart failure with preserved ejection fraction
Wang, Y, Quirino, C, Zagatina, A, Padang, Ratnasari , Kane, G C, Villarraga, Hector R. , Cortigiani, Lauro , Vazquez, J P, Boshchenko, A , Manganelli, F, Amor, Miguel , Yin, Lianghong , Picano, Eugenio , Boshchenko, Alla , Ryabova, Tamara , Yin, L, Pellikka, Patricia A.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | January 29, 2025 | Volume: 26 | Issue: Supplement_1 | Pages: No page available

10.1093/ehjci/jeae333.058 Get It

Abstract Background Heart failure and preserved ejection fraction (HFpEF) is a heterogeneous entity including patients with different phenotypes of reduced, normal, and supernormal left ventricular (LV) function. Objectives To assess the value of resting LV elastance with transthoracic echocardiography (TTE) to identify HFpEF phenotypes. Methods In a prospective, observational, multicenter study, 2380 HFpEF patients were recruited from July 2016 to May 2024 by 35 certified laboratories of 15 countries. HFpEF was diagnosed according to the European Society of Cardiology (ESC) guidelines. Systolic blood pressure (SBP) was measured. We assessed wall motion score index (WMSI), LV end-diastolic volume (EDV), end-systolic volume (ESV), EF, force (SBP/ESV), stroke volume (SV), arterial elastance (AE, SBP/SV), ventricular-arterial coupling (VAC, as SV/ESV), and left atrial volume index (LAVI). Global longitudinal strain (GLS) was available in 1164 (48.9%) patients. In 271 (11.4%) patients, N-terminal pro-brain natriuretic peptide (NT-proBNP) was assessed. Patients were divided into three groups based on rest force: low rest force group (< 25% percentile, Group 1), median rest force group (≥ 25% percentile & ≤ 75% percentile, Group 2), and high rest force group (> 75% percentile, Group 3). Results 330 (13.9%) patients presented with ischemic RWMA. The 3 groups showed a gradient with descending values (Group 3>2>1) for SBP, EF, GLS, AE, and VAC, with the opposite gradient (Group 1> 2> 3) for EDV, EDVi, ESV, ESVi, SV, SVi, and LAVI values (all P<0.01). Patients in Group 3 have higher NTproBNP level and higher percentage of B-line compared to groups 1 and 2 (P<0.05). The 3 groups were similar for values of coronary flow velocity, systolic pulmonary artery pressure, and E/e’ (see table). Univariable linear regression analysis showed that NTproBNP was correlated with force (r = 0.271, p < 0.001), VAC (r = 0.194, p = 0.001), LAVI (r = 0.327, p < 0.001), LVEDV (r = -0.245, p < 0.001), LVEDVi (r = -0.261, p < 0.001), LVESVi (r = -0.190, p = 0.002) and LVESV (r = -0.187, p = 0.002) (see figure). However, multivariable linear regression analysis showed that NTproBNP was independently associated with LAVI (β= 0.211, p < 0.001) and force (β= 1.804, p = 0.002). Conclusions HFpEF patients present with different LV contractile phenotypes, easily identified with resting LV force and volumetric TTE. LV force is linearly correlated with cardiac natriuretic peptide levels. The dominant hemodynamic feature of hypocontractile phenotype is a preload recruitment with dilation of LV EDV and normal SV, while the hypercontractile phenotype is characterized by a small LV with reduced SV. heat map
Fact or Myth? Black Patients Do Not Want to Participate in Clinical Trials
Mills, Krystal , Knight, RaKetra, Ekpo, Emem T., Lee, Lilian C. , Baldo, Lance , Xu, Chuanbo , Wang, Siqi , Adelman, Robert M. , Pemu, Priscilla, Levin, Theodore R. , Liu, Julia J. , Liu, Julia J , Figueroa, Francisco, Knight, RaKetra, Shaukat, Aasma

Mayo Clinic

Clinical and Translational Gastroenterology | January 29, 2025 | Volume: 16 | Issue: 4 | Pages: e00826

10.14309/ctg.0000000000000826 | PMID 39878425 Get It

INTRODUCTION: To assess strategies for optimizing participation of underserved minorities in a blood-based early colorectal cancer detection test study (PREEMPT CRC; NCT04369053) at a hospital serving primarily Black individuals. METHODS: Culturally sensitive, racially congruent research staff approached individuals undergoing average-risk screening colonoscopy. Consent/study procedures were synchronized with clinical appointments. Enrolled and not-enrolled patient characteristics were compared. Recruitment was compared with other study sites. RESULTS: In total, 247 of 509 eligible individuals were enrolled; most were identified as Black (88.7%). No baseline characteristics were associated with participation. Recruitment was high compared with other sites (11th centile). DISCUSSION: Recruitment barriers for Black individuals can be overcome when easy, culturally sensitive access is facilitated.
Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
Shaikh, Shafiq, Zhao, Xia , Wagner, Ryan T. , Hlady, Ryan A. , Ho, Thai H. , Robertson, Keith D. , Pan, Xiaoyu, Robertson, Keith D , Ho, Thai , Pan, Xiaoyu , Wang, Liguo

Mayo Clinic

Epigenetics | January 28, 2025 | Volume: 20 | Issue: 1 | Pages: No page available

10.1080/15592294.2025.2456418 | PMID 39874221 Get It

Large Language Models on Radiation Oncology Tasks: Small Fine-Tuned Models vs. Large Vanilla Model
Wang, P. , Liu, Tianming , Wang, Peilong , Liu, Zhengliang , Holmes, Jason , Liu, Wei

Mayo Clinic

No container title available | January 28, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.36227/techrxiv.173808198.86649534/v1 Get It

Purpose: This study compares the performance of small, fine-tuned LLMs with the large original models on two radiation oncology clinical tasks: treatment modality selection and ICD-10 code prediction. Methods: We used data of 403 treatment modality selection cases and 377 ICD-10 code prediction cases. The models used were fine-tuned LLaMA 2 7B and Mistral 7B, as well as the larger LLaMA 3.1 70B and 405B models for comparison. We evaluated the accuracy of all models on these two tasks. Results: Both fine-tuned LLaMA 2 7B and Mistral 7B outperformed LLaMA 3.1 70B and 405B in treatment modality selection task. The fine-tuned LLaMA 2 7B and Mistral 7B models achieved accuracy comparable to the larger models in ICD-10 code prediction. Conclusions: Small models, fine-tuned with radiation oncology data, can achieve performance comparable to-or even surpass-that of larger models.
Histopathological growth patterns of gastric cancer liver metastasis and their association with patient prognosis.
Sha, Dan , Zhuang, Q., Wang, Liguang , Jing, Haiyan , Tian, Chunfang , Yang, Qian , Sun, Jing , Wang, Jinshen , Song, Wei , Zhuang, Qingchun, Sinicrope, Frank A. , Zhang, Shuo

Mayo Clinic

Journal of Clinical Oncology | January 27, 2025 | Volume: 43 | Issue: 4_suppl | Pages: 484-484

10.1200/jco.2025.43.4_suppl.484 Get It

484 Background: The histopathological growth patterns (HGPs) of liver metastasis reflect the complicated and varied interactions between tumor cells and the host microenvironment. We studied HGPs of gastric cancer liver metastasis (GCLM) and sought to predict them using radiomic and clinical variables. Methods: Hepatectomy was performed in 62 patients with GCLM at our university hospital between 2011 and 2021. HGPs were evaluated according to international consensus guidelines, and were classified as either desmoplastic HGP (dHGP) or non-dHGP. CD4, CD8, VEGF and CD31 were analyzed by immunohistochemistry. Eight hundred and fifty-one radiomics features were extracted from CT portal venous phase images and the optimal radiomics signature was determined by univariate analysis and LASSO regression. Multivariable regression analyses and ROC curves were used to assess the predictive performance of HGPs with a radiomic and clinical combined model. Results: Among 62 patients, 14 were categorized as dHGP, and 48 as non-dHGP. Non-dHGP vs. d-HGP was associated with higher tumor N stage and CEA level, and with decreased CD8 + T cells, and lower VEGF and CD31 expression. HGP status was independently associated with patient cancer-specific survival (CSS) (P<0.05) multivariately.Analysis of percent relative contribution revealed that HGP ranked first for CSS (35.9%), ahead of T (28.9%) and N (28.9%) stage. A model with combined radiomic and clinical features demonstrated robust performance with area under the curve (AUC) values of 0.993 and 0.933 in the training and validation sets, respectively. Conclusions: Non-invasive determination of radiomic and clinical features was shown to predict HGPs types. Compared to dHGP, GCLM with non-dHGP exhibited significantly lower immune cell infiltration and decreased angiogenesis. Among features examined in GCLM, HGP was the most robust for prognostication. Univariate and multivariate analysis of prognostic factors for cancer-specific survival. Characteristics Univariate analysis Multivariate rergression analysis HR (95%CI) P HR (95%CI) P Gender ( Women vs Men ) 1.13(0.61-2.09) 0.71 Age ( >60years vs ≤60years) 1.08(0.60-1.70) 0.98 HGP ( non-desmoplastic HGP vs desmoplastic HGP ) 3.63(1.78-7.41) 0.00 3.48(1.37-8.88) 0.01 T stage ( T3-T4 vs T1-T2 ) 2.03(1.08-3.80) 0.03 2.29(1.15-4.58) 0.02 N stage ( N1-N3 vs N0 ) 3.46(1.66-7.23) 0.00 2.54(1.17-5.56) 0.02 CEA ( >5ng/ml vs ≤5ng/ml ) 2.37(1.25-4.48) 0.01 1.56(0.70-3.48) 0.27